active neuron cells synapse network

Intellectual Property

Opiant has 8 Orange Book listed patents covering NARCAN® Nasal Spray and several other patents pending. The Company also has 1 licensed patent and several licensed pending applications for the heroin vaccine from Walter Reed Army Institute of Research (WRAIR) and National Institute on Drug Abuse (NIDA), and 5 licensed patents from Sanofi for drinabant. We have a number of patent applications on file and will continue to strengthen our patent portfolio on a continuing basis.

Opiant has also licensed the global rights for the use of Intravail®, an absorption enhancer from Aegis Therapeutics (now a part of Neurelis), for use in our opioid antagonist nasal spray technology.